ID17334A - LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY - Google Patents

LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY

Info

Publication number
ID17334A
ID17334A IDP971318A ID971318A ID17334A ID 17334 A ID17334 A ID 17334A ID P971318 A IDP971318 A ID P971318A ID 971318 A ID971318 A ID 971318A ID 17334 A ID17334 A ID 17334A
Authority
ID
Indonesia
Prior art keywords
latest
inhibitors used
used parenterally
pharmacy formulation
trombin
Prior art date
Application number
IDP971318A
Other languages
Indonesian (id)
Inventor
Anna Lundgren
Ulla Stjernfelt
Original Assignee
Astra Aktiebilag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebilag filed Critical Astra Aktiebilag
Publication of ID17334A publication Critical patent/ID17334A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP971318A 1996-04-24 1997-04-21 LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY ID17334A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
ID17334A true ID17334A (en) 1997-12-18

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971318A ID17334A (en) 1996-04-24 1997-04-21 LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY

Country Status (6)

Country Link
AR (1) AR006664A1 (en)
AU (1) AU2719597A (en)
ID (1) ID17334A (en)
SE (1) SE9601556D0 (en)
WO (1) WO1997039770A1 (en)
ZA (1) ZA973062B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (en) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (en) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (en) * 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (en) * 1999-05-11 2001-07-27 Synthelabo GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
SE9902202D0 (en) 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (en) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (en) 2000-12-01 2004-05-05 Astrazeneca Ab MANDELIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE DERIVATIVES, USE OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES, AND INTERMEDIARY COMPOUNDS
SE0101762D0 (en) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201661D0 (en) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201658D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
PT1569912E (en) 2002-12-03 2015-09-15 Pharmacyclics Llc 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
IN2014MN02245A (en) * 2012-04-10 2015-10-09 Rubicon Res Private Ltd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DK93993D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN FOR THE PREPARATION OF A SYSTEMIC ANALGETIC OPIOID PREPARATION

Also Published As

Publication number Publication date
SE9601556D0 (en) 1996-04-24
ZA973062B (en) 1997-10-24
AR006664A1 (en) 1999-09-08
AU2719597A (en) 1997-11-12
WO1997039770A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
ID17334A (en) LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY
ID19198A (en) HETEROSICLIC METALOPROTEASE INHIBITORS
ID18416A (en) DIHETEROSICLIC METALOPROTEASE INHIBITORS
IS5574A (en) Substituting the Xa component of the oxo-heterocyclyl inhibitor
NO942064D0 (en) inhibitors
ID18141A (en) 1,3-DIHETEROSICLIC METALOPROTEASE INHIBITORS
IL137540A0 (en) Inhibitors of phospholipase a2
IL136812A0 (en) Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
ZA9811876B (en) Prodrugs of naaladase inhibitors
NO992821D0 (en) Ketobenzamides as Calpain Inhibitors
FI963597A0 (en) Isoprenyylitransferaasi inhibitors
NO972930D0 (en) Fibronectin-adhesion inhibitors
ID27574A (en) ENZYMER INHIBITORS
FI972160A (en) Matriisimetalloproteaasi inhibitors
DK1027332T3 (en) New lactametalloprotease inhibitors
ATE230275T1 (en) ANGIOGENSIS INHIBITOR
DK0958287T3 (en) Sulfamidmetalloprotease inhibitors
PT858464E (en) TROMBIN INHIBITORS
BR9606799A (en) Corrosion inhibitor formulations improved with calcium nitrite
NO931947D0 (en) PROCEDURE FOR CORROSION INHIBITION
PT927183E (en) SPIROCYLIC INHIBITORS OF METALOPROTEASES
PT1047450E (en) ACE INHIBITOR COMBINATIONS - MMP INHIBITOR
EP1084098A4 (en) Inhibitors of the anandamide transporter as analgesic agents
NO993626L (en) Mixture comprising an oil-soluble deposition inhibitor
NO975073L (en) Low toxic corrosion inhibitor